Barclay A Phillips's Net Worth

$853 Thousand

Estimate Recalculated Nov 1, 2024 09:21AM EST

Who is Barclay A Phillips?

Barclay A Phillips does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include IMMUNIC, INC., NOVAVAX INC, G1 Therapeutics, Inc., ACORDA THERAPEUTICS INC, and MICROMET, INC..

SEC CIK

Barclay A Phillips's CIK is 0001265801

Past Insider Trading and Trends

2014 was Barclay A Phillips's most active year for acquiring shares with 5 total transactions. Barclay A Phillips's most active month to acquire stocks was the month of May. 2012 was Barclay A Phillips's most active year for disposing of shares, totalling 8 transactions. Barclay A Phillips's most active month to dispose stocks was the month of February. 2018 saw Barclay A Phillips paying a total of $97,300.00 for 5,000 shares, this is the most they've acquired in one year. In 2012 Barclay A Phillips cashed out on 611,691 shares for a total of $2,897,103.82, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

IMMUNIC, INC. (IMUX) Snapshot price: $1.34

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Jun 11
Form 4
—
0
—
—
0
Mar 4
Form 4
—
0
—
—
0
Jun 28
Form 4
—
0
—
—
0
Jun 15
Form 4
—
0
—
—
0
Jun 10
Form 4
—
0
—
—
0
Jul 2
Form 4
—
0
—
—
0
Nov 18
Form 3
—
0
—
—
0
No matching records found

NOVAVAX INC (NVAX) Snapshot price: $11.6

SVP, Chief Financial Officer

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+5.62%
2.06K
$0.89
$1,830.73
38.67K
Jul 31
Form 4
+215.29%
25K
$0.84
$20,950.00
36.61K
May 11
Form 4
+16.36%
1.63K
$1.12
$1,828.96
11.61K
Jan 31
Form 4
—
0
—
—
0
Nov 14
Form 4
+4.42%
422
$4.29
$1,810.38
9.98K
Jul 31
Form 4
—
0
—
—
0
Mar 15
Form 4
+4.43%
405
$4.38
$1,773.90
9.56K
Jan 31
Form 4
-75.79%
-28.66K
$13.06
-$374,323.37
9.15K
Aug 19 - Aug 20
Form 4
+2.06%
764
$2.28
$1,741.92
37.81K
Jul 31
Form 4
—
0
—
—
0
Mar 5
Form 4
+29.27%
8.39K
$2.28
$19,124.64
37.04K
Jan 31
Form 4
+21.14%
5K
$4.11
$20,549.50
28.66K
Oct 3
Form 4
+59.11%
8.79K
$2.28
$20,036.64
23.66K
Jul 31
Form 4/A
+50.67%
5K
$4.25
$21,225.00
14.87K
Mar 25
Form 4
-25.17%
-5.00K
$4.25
-$21,225.00
14.87K
Mar 25
Form 4
—
0
—
—
0
Mar 6
Form 4
∞
9.87K
$2.29
$22,597.72
9.87K
Jan 31
Form 4/A
—
0
—
—
0
Jun 12
Form 3
—
0
—
—
0
Form 4
+33.33%
50K
$1.90
$95,000.00
200K
Jun 12
No matching records found

G1 Therapeutics, Inc. (GTHX) Snapshot price: $7.12

SVP & Chief Financial Officer

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Jan 2
Form 4
—
0
$29.69
-$102,291.00
0
Scheduled
Nov 15
Form 4
—
0
—
—
0
Dec 6
Form 3
—
0
—
—
0
No matching records found

ACORDA THERAPEUTICS INC (ACOR) No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-19.43%
-235.00K
$30.55
-$7,120,079.02
974.74K
Jun 13
Form 4
—
0
—
—
0
May 21
Form 4
—
0
—
—
0
Aug 6
Form 4
—
0
—
—
0
Dec 1
Form 4
∞
543.8K
—
—
543.8K
Feb 15
Form 3
—
0
—
—
0
No matching records found

MICROMET, INC. No price found

SVP, CFO

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Mar 7
Form 4
-100.00%
-1.48K
$11.00
-$16,313.00
0
Mar 2
Form 4
—
0
—
—
0
Mar 1
Form 4
—
0
—
—
0
Apr 1
Form 4
—
0
—
—
0
Jan 29
Form 4
-100.00%
-334.11K
$4.32
-$124,705.00
0
Aug 29 - Nov 9
Form 4
—
0
—
—
0
Apr 1
Form 4
—
0
—
—
0
Sep 1
Form 4
—
0
—
—
0
Jun 27
Form 4
—
0
—
—
0
Jun 28
Form 4
—
0
—
—
0
May 5
Form 4
—
0
—
—
0
Jun 14
Form 4
—
0
—
—
0
Jun 10
Form 4
∞
1.01M
$12.00
—
1.01M
Nov 4
Form 3
—
0
—
—
0
No matching records found